Fingerprint
Dive into the research topics of 'TBCRC 002: A phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically